Acceder

Contenidos recomendados por jmsl2015

jmsl2015 10/12/20 14:52
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
 MODERNA : We just announced that the first adolescent participants have been dosed in the Phase 2/3 study of mRNA-1273, our vaccine candidate against COVID-19, in adolescents ages 12 to less than 18. Read more: https://buff.ly/2Iz5li6 J&J :  Johnson & Johnson is cutting the size of its pivotal U.S. Covid-19 vaccine trial — the only major study testing a single dose of a Covid vaccine — from 60,000 volunteers to 40,000 volunteers. 
Ir a respuesta
jmsl2015 10/12/20 14:46
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
Premarket: -3,65%   y los índices con muestras de corrección, objetivo bajista del Sp500 a los 3600 ptos.Necesitamos alguna buena noticia :(
Ir a respuesta
jmsl2015 03/12/20 21:51
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
 BREAKING: Pfizer will only ship half the vaccine doses it had planned this year, due to raw ingredient quality issues. The company had hoped to ship 100 million doses, but it will now only be 50 million. They still anticipate 1 billion+ doses in 2021. Developing story..  !!!!  21:43 
Ir a respuesta
jmsl2015 01/12/20 13:01
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
Saudi Arabia in Talks to Acquire Leading Vaccine Candidates Saudi Arabia is in talks to acquire vaccines from AstraZeneca, Pfizer, Moderna, Johnson & Johnson and Novavax, with Riyadh expecting to meet up to 20% of its national need through the World Health Organization’s Covax initiative. https://www.wsj.com/livecoverage/covid-2020-12-01 
Ir a respuesta